We are live on ! Find out more
PFBT

Parkside Financial Bank & Trust Portfolio holdings

AUM $1.31B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+19.14%
3 Year Est. Return
+63.35%
5 Year Est. Return
+76.33%
10 Year Est. Return
+246.44%
AUM
$929M
AUM Growth
+$142M
Cap. Flow
+$78.9M
Cap. Flow %
8.49%
Top 10 Hldgs %
27.88%
Holding
3,046
New
312
Increased
1,403
Reduced
676
Closed
314

Top Buys

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$7.54M
2
TNGY
Tortoise Energy ETF
TNGY
+$5.18M
3
SPSM icon
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
+$3.92M
4
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$2.61M
5
MSFT icon
Microsoft
MSFT
+$2.51M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$2.03M
2
AMJB icon
Alerian MLP Index ETNs due January 28 2044
AMJB
+$1.37M
3
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$1.25M
4
ITM icon
VanEck Intermediate Muni ETF
ITM
+$779K
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$730K

Sector Composition

Rank Sector Weight
1 Technology 15.73%
2 Financials 8.44%
3 Healthcare 6.22%
4 Consumer Discretionary 5.06%
5 Industrials 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RRR icon
2526
Red Rock Resorts
RRR
$3.67B
$521 ﹤0.01%
10
-10
-50% -$457
CGON icon
2527
CG Oncology
CGON
$6.62B
$520 ﹤0.01%
20
– –
MDXG icon
2528
MiMedx Group
MDXG
$612M
$520 ﹤0.01%
+85
New +$565
BLMN icon
2529
Bloomin' Brands
BLMN
$924M
$518 ﹤0.01%
60
– –
CLOV icon
2530
Clover Health Investments
CLOV
$2.38B
$517 ﹤0.01%
+185
New +$608
INTA icon
2531
Intapp
INTA
$3.16B
$517 ﹤0.01%
10
-10
-50% -$546
PACS icon
2532
PACS Group
PACS
$7.12B
$517 ﹤0.01%
40
– –
INDV icon
2533
Indivior Pharmaceuticals
INDV
$4.51B
$516 ﹤0.01%
+35
New +$408
NTLA icon
2534
Intellia Therapeutics
NTLA
$1.66B
$516 ﹤0.01%
55
-45
-45% -$370
BEAM icon
2535
Beam Therapeutics
BEAM
$2.74B
$511 ﹤0.01%
30
+10
+50% +$174
CSTL icon
2536
Castle Biosciences
CSTL
$933M
$511 ﹤0.01%
25
+5
+25% +$93
ALIT icon
2537
Alight
ALIT
$394M
$510 ﹤0.01%
5
-3
-38% -$321
CLDX icon
2538
Celldex Therapeutics
CLDX
$3.35B
$510 ﹤0.01%
25
-15
-38% -$292
COGT icon
2539
Cogent Biosciences
COGT
$6.47B
$510 ﹤0.01%
71
+6
+9% +$33
TRTX
2540
TPG RE Finance Trust
TRTX
$616M
$510 ﹤0.01%
66
+6
+10% +$46
HVT icon
2541
Haverty Furniture Companies
HVT
$450M
$509 ﹤0.01%
+25
New +$488
LAND
2542
Gladstone Land Corp
LAND
$358M
$509 ﹤0.01%
+50
New +$491
ARKO icon
2543
ARKO Corp
ARKO
$505M
$508 ﹤0.01%
+120
New +$524
BHVN icon
2544
Biohaven
BHVN
$2.24B
$508 ﹤0.01%
36
-9
-20% -$160
EEFT icon
2545
Euronet Worldwide
EEFT
$2.78B
$507 ﹤0.01%
5
– –
HOUS
2546
DELISTED
Anywhere Real Estate
HOUS
$507 ﹤0.01%
+140
New +$488
RXRX icon
2547
Recursion Pharmaceuticals
RXRX
$1.78B
$506 ﹤0.01%
100
-65
-39% -$319
VERV
2548
DELISTED
Verve Therapeutics
VERV
$506 ﹤0.01%
45
-25
-36% -$143
TTI icon
2549
TETRA Technologies
TTI
$1.25B
$504 ﹤0.01%
+150
New +$437
OFIX icon
2550
Orthofix Medical
OFIX
$415M
$503 ﹤0.01%
45
+15
+50% +$186
100 101
102
103 104

Similar funds

PCM
Prelude Capital Management New York $1.31B AUM 62.02% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
COCM
Charter Oak Capital Management Portsmouth, New Hampshire $1.29B AUM 13.93% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Parkside Financial Bank & Trust's Q2 2025 Portfolio in Review

As of Q2 2025, Parkside Financial Bank & Trust held 3,046 positions worth $929M, up 18% from $788M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Parkside Financial Bank & Trust deployed $78.9M of net new capital in Q2 2025, opening 312 new positions and adding to 1,403 existing holdings. Its largest new stake was Tortoise Energy ETF: 566,715 shares worth $5.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $2.03M trimmed.

  • Parkside Financial Bank & Trust's largest Q2 2025 buy was Tortoise Energy ETF: 566,715 shares worth $5.2M.
  • Parkside Financial Bank & Trust added most to Roivant Sciences in Q2 2025, an estimated $7.54M increase.
  • Parkside Financial Bank & Trust's biggest Q2 2025 reduction was iShares MSCI EAFE ETF, cutting an estimated $2.03M.
  • Parkside Financial Bank & Trust fully exited Discover Financial Services in Q2 2025, selling an estimated $354K.
  • Parkside Financial Bank & Trust's ten largest holdings make up 28% of its $929M portfolio in Q2 2025.
  • Parkside Financial Bank & Trust opened 312 new positions and closed 314 in Q2 2025.
  • Parkside Financial Bank & Trust's portfolio value rose 18% quarter-over-quarter to $929M.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.